FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2992110006> ?p ?o ?g. }

• W2992110006 endingPage "182" @default.
• W2992110006 startingPage "170" @default.
• W2992110006 abstract "<b><i>Objectives:</i></b> To systematically review the effect and safety of epicutaneous immunotherapy (EPIT) for allergic diseases. <b><i>Methods:</i></b> We searched PubMed, EMBASE, Cochrane Central Register of Controlled Trials, China National Knowledge Infrastructure, CQ VIP Database, Wanfang Data, and international trial register from their inception to July 29, 2019, without language restrictions, for randomized controlled trials (RCTs) that compared EPIT versus no EPIT for allergen-triggered allergic reactions. We assessed certainty of evidence by the GRADE approach. <b><i>Results:</i></b> Ten RCTs with 1,085 participants (aged from 10 months to 65 years) comparing EPIT with placebo for peanut, cow milk, or grass-pollen allergy met the eligibility criteria. A substantial benefit in terms of desensitization in EPIT group was more likely for peanut or cow milk protein allergy (risk ratio [RR] 2.34, 95% CI 1.69–3.23; <i>I</i>² = 0%; high certainty evidence). EPIT increased local-treatment-related adverse events (L-TRAE; RR 1.56, 95% CI 1.03–2.36; <i>I</i>² = 82%; moderate certainty evidence). But there were no significantly increased risk of any TRAEs (low certainty evidence) or systemic-TRAEs (S-TRAEs; very low certainty evidence) in EPIT group. The incidence rate of serious AEs, the use of rescue medications, and anaphylactic reactions stratified by organ systems including skin and mucosa, eyes and upper respiratory, lower respiratory, and gastrointestinal system in EPIT group were similar to placebo group. In subgroup analysis, desensitization of EPIT was significantly effective in peanut allergy (RR 2.29, 95% CI 1.64–3.21; <i>I</i>² = 0%) and children &#x3c;12 years (RR 2.85, 95% CI 1.92–4.24; <i>I</i>² = 0%) with high certainty evidence. Only epicutaneous grass-pollen immunotherapy significantly increased the risk of S-TRAE (RR 4.65, 95% CI 1.10–19.64; <i>I</i>² = 0%). <b><i>Conclusion:</i></b> The systematic review suggests that EPIT might induce desensitization in peanut allergy and an increased risk of local AEs. These findings should be interpreted with caution owing to the limited study and heterogeneity. More data in the older (children ≥12 years and adults) and other allergic diseases are needed." @default.
• W2992110006 created "2019-12-13" @default.
• W2992110006 creator A5004392554 @default.
• W2992110006 creator A5016854610 @default.
• W2992110006 creator A5046233460 @default.
• W2992110006 creator A5056677068 @default.
• W2992110006 creator A5065889355 @default.
• W2992110006 date "2019-12-04" @default.
• W2992110006 modified "2023-09-30" @default.
• W2992110006 title "The Efficacy and Safety of Epicutaneous Immunotherapy for Allergic Diseases: A Systematic Review and Meta-Analysis" @default.
• W2992110006 cites W1988733403 @default.
• W2992110006 cites W1996846019 @default.
• W2992110006 cites W2042015803 @default.
• W2992110006 cites W2043295004 @default.
• W2992110006 cites W2050387062 @default.
• W2992110006 cites W2054815046 @default.
• W2992110006 cites W2103217900 @default.
• W2992110006 cites W2113034303 @default.
• W2992110006 cites W2121760095 @default.
• W2992110006 cites W2126930838 @default.
• W2992110006 cites W2131276393 @default.
• W2992110006 cites W2132885099 @default.
• W2992110006 cites W2139652104 @default.
• W2992110006 cites W2168981024 @default.
• W2992110006 cites W2278696076 @default.
• W2992110006 cites W2284318603 @default.
• W2992110006 cites W2398632573 @default.
• W2992110006 cites W2541170535 @default.
• W2992110006 cites W2550270455 @default.
• W2992110006 cites W2569125595 @default.
• W2992110006 cites W2587710090 @default.
• W2992110006 cites W2756837779 @default.
• W2992110006 cites W2757586023 @default.
• W2992110006 cites W2768781972 @default.
• W2992110006 cites W2792695089 @default.
• W2992110006 cites W2900740291 @default.
• W2992110006 cites W2901755923 @default.
• W2992110006 cites W2902381752 @default.
• W2992110006 cites W2916224422 @default.
• W2992110006 cites W2942283768 @default.
• W2992110006 cites W2943606448 @default.
• W2992110006 cites W2945740780 @default.
• W2992110006 cites W4240430066 @default.
• W2992110006 cites W4255228992 @default.
• W2992110006 doi "https://doi.org/10.1159/000504366" @default.
• W2992110006 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31801149" @default.
• W2992110006 hasPublicationYear "2019" @default.
• W2992110006 type Work @default.
• W2992110006 sameAs 2992110006 @default.
• W2992110006 citedByCount "15" @default.
• W2992110006 countsByYear W29921100062020 @default.
• W2992110006 countsByYear W29921100062021 @default.
• W2992110006 countsByYear W29921100062022 @default.
• W2992110006 countsByYear W29921100062023 @default.
• W2992110006 crossrefType "journal-article" @default.
• W2992110006 hasAuthorship W2992110006A5004392554 @default.
• W2992110006 hasAuthorship W2992110006A5016854610 @default.
• W2992110006 hasAuthorship W2992110006A5046233460 @default.
• W2992110006 hasAuthorship W2992110006A5056677068 @default.
• W2992110006 hasAuthorship W2992110006A5065889355 @default.
• W2992110006 hasConcept C120665830 @default.
• W2992110006 hasConcept C121332964 @default.
• W2992110006 hasConcept C126322002 @default.
• W2992110006 hasConcept C142724271 @default.
• W2992110006 hasConcept C168563851 @default.
• W2992110006 hasConcept C170493617 @default.
• W2992110006 hasConcept C197934379 @default.
• W2992110006 hasConcept C203014093 @default.
• W2992110006 hasConcept C204787440 @default.
• W2992110006 hasConcept C207480886 @default.
• W2992110006 hasConcept C27081682 @default.
• W2992110006 hasConcept C2779779143 @default.
• W2992110006 hasConcept C44249647 @default.
• W2992110006 hasConcept C61511704 @default.
• W2992110006 hasConcept C71924100 @default.
• W2992110006 hasConcept C82789193 @default.
• W2992110006 hasConcept C95190672 @default.
• W2992110006 hasConceptScore W2992110006C120665830 @default.
• W2992110006 hasConceptScore W2992110006C121332964 @default.
• W2992110006 hasConceptScore W2992110006C126322002 @default.
• W2992110006 hasConceptScore W2992110006C142724271 @default.
• W2992110006 hasConceptScore W2992110006C168563851 @default.
• W2992110006 hasConceptScore W2992110006C170493617 @default.
• W2992110006 hasConceptScore W2992110006C197934379 @default.
• W2992110006 hasConceptScore W2992110006C203014093 @default.
• W2992110006 hasConceptScore W2992110006C204787440 @default.
• W2992110006 hasConceptScore W2992110006C207480886 @default.
• W2992110006 hasConceptScore W2992110006C27081682 @default.
• W2992110006 hasConceptScore W2992110006C2779779143 @default.
• W2992110006 hasConceptScore W2992110006C44249647 @default.
• W2992110006 hasConceptScore W2992110006C61511704 @default.
• W2992110006 hasConceptScore W2992110006C71924100 @default.
• W2992110006 hasConceptScore W2992110006C82789193 @default.
• W2992110006 hasConceptScore W2992110006C95190672 @default.
• W2992110006 hasIssue "3" @default.
• W2992110006 hasLocation W29921100061 @default.
• W2992110006 hasLocation W29921100062 @default.
• W2992110006 hasOpenAccess W2992110006 @default.

• next